My Companies
Notification
Account
Log Out
Login
Gland Pharma appointed Deepak Sapra as CEO effective November 16, 2026, subject to offer acceptance. Sapra currently leads Dr. Reddy’s API and Services business and brings over 23 years of pharmaceutical experience spanning generics, APIs, CDMO, global expansion and portfolio strategy. Context: aligns with the company’s CDMO-led growth strategy.
Gland Pharma Schedules UTI, Ashmore And Motilal Oswal Investor Meetings
Gland Pharma Secures USD 90–100 Million Annualized CDMO Partnership
Gland Pharma Secures USFDA Approval For Sugammadex Generic Injection